Company Profile

Genomic Vision is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics

 

 

News

 

14/12/2015

Genomic Vision and Reims University Hospital Launch Clinical Study to Establish New Screening Tool for Early Detection and Prevention of Cervical Cancer

plus_blue    pdf_red
 

03/12/2015

Genomic Vision signs a strategic partnership with the Imagine Institute, the largest European genetic research and care cluster

plus_blue    pdf_red
 

15/10/2015

GENOMIC VISION and ROUEN University Hospital launch a trial to improve genetic counseling for Infantile Spinal Muscular Atrophy in France

plus_blue    pdf_red
 

09/06/2015

Genomic Vision selected for the Horizon 2020 program’s ‘BeyondSeq’ project with a total grant of €6 million

plus_blue    pdf_red
 

15/03/2015

Financial information at March 31, 2015

plus_blue    pdf_red
 

15/03/2015

FYR 2014 in line with the Company's buoyant development
Total revenue from activity: €4.9 million
Operating costs under control
Solid cash position of €22.8 million

plus_blue    pdf_red
 

17/02/2015

Genomic Vision renews its Strategic Collaboration with Quest Diagnostics for three more years

plus_blue    pdf_red
 

09/02/2015

Financial Agenda 2015

plus_blue    pdf_red
 

15/01/2015

2014 Annual Revenue from Sales at €3.5 Million

plus_blue    pdf_red
 

07/01/2015

Genomic Vision achieves major milestone with delivery of new high-throughput genome analyzer to Quest Diagnostics

plus_blue    pdf_red
 

news

 

genomic_web_visuels_footer_COMPANY